Skip to Content

Ozone Concentrations Linked to Fibroids in Black Women

FRDAY, May 14, 2021 -- Ozone (O3) concentrations are associated with an increased risk for uterine leiomyomata (UL) in Black women, according to a study published online May 13 in Human Reproduction.

Amelia K. Wesselink, Ph.D., from the Boston University School of Public Health, and colleagues conducted a study involving 21,998 premenopausal Black women residing in 56 U.S. metropolitan areas from 1997 to 2011 to examine the association between ambient concentrations of particulate matter <2.5 microns (PM2.5), nitrogen dioxide (NO2), and O3 with the risk for UL.

The researchers found that 28.4 percent of participants reported physician-diagnosed UL confirmed by ultrasound or surgery during 196,685 person-years of follow-up. There was no appreciable association seen for concentrations of PM2.5 (hazard ratio for a one-interquartile range [IQR] increase, 1.01; 95 percent confidence interval, 0.93 to 1.10) or NO2 (hazard ratio for a one-IQR increase, 1.05; 95 percent confidence interval, 0.95 to 1.16) with UL; however, O3 concentrations were associated with an increased risk for UL (hazard ratio for a one-IQR increase, 1.19; 95 percent confidence interval, 1.07 to 1.32). Among women aged younger than 35 years and parous women, the association was stronger (hazard ratios, 1.26 [95 percent confidence interval, 0.98 to 1.62] and 1.28 [95 percent confidence interval, 1.11 to 1.48], respectively).

"There have now been three studies suggesting a link between air pollution and fibroids, but ours is the first to show this in Black women," Wesselink said in a statement. "Because Black women are inequitably exposed to air pollution, these findings have important implications for racial disparity in fibroids."

One author disclosed ties to the pharmaceutical and medical device industries.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Read this next

Relugolix Combo Therapy Beneficial for Fibroid-Related Menorrhagia

THURSDAY, Feb. 18, 2021 -- For patients with uterine fibroids, once-daily relugolix combination therapy results in significantly reduced menstrual bleeding compared with placebo...

Fibroid-Related QOL Better With Myomectomy for Uterine Fibroids

THURSDAY, July 30, 2020 -- For women with symptomatic uterine fibroids, fibroid-related quality of life at two years is better for those undergoing myomectomy than those...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.